Glycated hemoglobin in ST-elevation myocardial infarction without previously known diabetes: Its short and long term prognostic role

Chiara Lazzeri, Serafina Valente, Marco Chiostri, Claudio Picariello, Paola Attanà, Gian Franco Gensini

Research output: Contribution to journalArticlepeer-review

Abstract

In 518 consecutive STEMI non-diabetic patients, glycated hemoglobin > 6.5% was not associated with increased short and long term mortality, but was associated with higher admission glucose values, worse in-hospital glycemic control and a higher incidence of acute insulin resistance (HOMA index).

Original languageEnglish
JournalDiabetes Research and Clinical Practice
Volume95
Issue number1
DOIs
Publication statusPublished - Jan 2012

Keywords

  • Glycated hemoglobin
  • Non diabetic
  • Prognosis
  • STEMI

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Endocrinology

Fingerprint Dive into the research topics of 'Glycated hemoglobin in ST-elevation myocardial infarction without previously known diabetes: Its short and long term prognostic role'. Together they form a unique fingerprint.

Cite this